Delivery Order SPE2DB20D9226-SPE2DB25FQ61S
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on July 22, 2025. The delivery order is for EXPAREL 266 mg/20 mL vials, a liposomal bupivacaine product used for post-operative pain management. The contract carries no set-aside designation and requires ultimate completion by August 12, 2025, with performance to be executed...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $42,185.32 by the Defense Logistics Agency (DLA) on September 12, 2025. The order covers the supply of EXPAREL 266 mg/20 ml vials, a liposomal bupivacaine product used for local anesthesia and pain management in surgical and medical applications. This is a firm fixed-price delivery order with no set-aside designation, reflecting the company's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,218.44 by the Defense Logistics Agency (DLA) on September 4, 2025. The contract calls for the delivery of EXPAREL 133 mg/10 mL vials, a liposomal bupivacaine product used for local anesthetic infiltration during surgical procedures. The delivery order is set to be completed by September 25, 2025, with performance occurring...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, with a ceiling value of $20,085.04. The contract calls for the delivery of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials, a long-acting local anesthetic used in surgical and medical settings. The award carries no set-aside designation and is scheduled for ultimate completion...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $30,127.56 on July 14, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract covers the supply of EXPAREL 266 mg/20 ml vials, a liposomal bupivacaine local anesthetic used in surgical and post-operative pain management. The delivery order is firm fixed price with an ultimate completion date of August 4, 2025, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. This firm fixed-price delivery order carries a ceiling value of $37.4K and represents a task order under the company's larger Indefinite Delivery Contract with DLA valued at $500M through November 2026. The contract requires ultimate...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $12,553.15 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on July 24, 2025. The delivery order calls for the supply of EXPAREL 1.3% in 20-milliliter quantities (10 units), a liposomal bupivacaine formulation used for surgical site infiltration and interscalene brachial plexus nerve block. The contract carries no...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on August 12, 2025. The contract calls for the delivery of EXPAREL 266 mg/20 mL vials, a local anesthetic medication used in surgical and pain management applications. The delivery order was issued without a set-aside designation and carries an ultimate completion date of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,063.78 by the Defense Logistics Agency on July 25, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,414.04 by the Defense Logistics Agency (DLA) on September 2, 2025. The contract calls for delivery of EXPAREL 133 mg/10 ml vials, a local anesthetic medication used in surgical and pain management applications. The delivery is scheduled for completion by September 23, 2025, with performance taking place at the vendor's...
- SPE2DB20D9226Indefinite Delivery Contract
- SPE2DB20D9226-SPE2DB25FQ61SDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on June 2, 2025. The contract calls for the delivery of EXPAREL 266 mg/20 mL vials, a liposomal bupivacaine local anesthetic commonly used in surgical and post-operative pain management. The delivery order is scheduled for completion by June 24, 2025, with the place of performance in Park Ridge, Illinois. No set-aside designation was used for this award. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total value of $499,999,999 and remains valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for pharmaceutical products supporting medical supply needs across military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing delivery orders for an extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables distributed directly to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 6/2/25 |